Literature DB >> 3872106

Apparent prevalence of curable hypertension in the Hypertension Detection and Follow-up Program.

A Lewin, M D Blaufox, H Castle, G Entwisle, H Langford.   

Abstract

Data describing the 5,485 participants in the stepped-care group of the Hypertension Detection and Follow-up Program were reviewed to determine the apparent prevalence of renal parenchymal and reversible, secondary hypertension. The investigation was limited and was not designed to identify all cases of secondary hypertension. Baseline prevalence of proteinuria was 3.6%, pyuria 7.1%, hematuria 5.1%, and elevated serum creatinine level (greater than or equal to 1.7 mg/dL) 2.7%. The combined occurrence of an elevated serum creatinine level plus one or more urinary abnormalities was noted in 0.95%. Initial review of case reports revealed six participants with hypertension secondary to use of birth control pills and three participants with hypertension that was proved to be secondary to renovascular disease. Specific laboratory or historical criteria were used as indications for more intensive investigation in an additional 65 participants. Among these individuals, one participant with renovascular disease and three with possible primary hyperaldosteronism were identified. A rapid-sequence intravenous urogram or radionuclide scan was performed on another subgroup of 62 participants whose hypertension was "poorly" controlled (diastolic BP, greater than or equal to 95 mm Hg). Fifty-nine studies were negative, one was positive, and two were equivocal. These results suggest that the frequency of clinically relevant cases of reversible, secondary hypertension, at least among individuals with mild to moderate elevation of blood pressure, is low.

Entities:  

Mesh:

Year:  1985        PMID: 3872106

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  16 in total

Review 1.  Evidence based management of hypertension: What to do when blood pressure is difficult to control.

Authors:  J E O'Rorke; W S Richardson
Journal:  BMJ       Date:  2001-05-19

Review 2.  Endovascular Treatment of Renal Artery Stenosis in the Post CORAL Era.

Authors:  Paul J O'Connor; Robert A Lookstein
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-08

Review 3.  Proteinuria as a prognostic factor during long term hypertensive care.

Authors:  O Samuelsson
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 4.  Providing health services for the homeless: a stitch in time.

Authors:  P W Brickner; J M McAdam; R A Torres; W J Vicic; B A Conanan; T Detrano; O Piantieri; B Scanlan; L K Scharer
Journal:  Bull N Y Acad Med       Date:  1993

5.  The current state of endovascular therapy in the evaluation and management of renovascular disease.

Authors:  Praveen R Anchala; Scott A Resnick
Journal:  Semin Intervent Radiol       Date:  2009-12       Impact factor: 1.513

6.  3D FIESTA pulse sequence for assessing renal artery stenosis: is it a reliable application in unenhanced magnetic resonance angiography?

Authors:  Caterina Gaudiano; Fiorenza Busato; Emiliana Ferramosca; Carlo Cecchelli; Beniamino Corcioni; Lucia Barbara De Sanctis; Antonio Santoro; Rita Golfieri
Journal:  Eur Radiol       Date:  2014-07-25       Impact factor: 5.315

7.  Cost effectiveness in the detection of renal artery stenosis.

Authors:  W L England; C E Grim; M H Weinberger; S D Roberts
Journal:  J Gen Intern Med       Date:  1988 Jul-Aug       Impact factor: 5.128

Review 8.  Renal Artery Stenosis: Optimal Therapy and Indications for Revascularization.

Authors:  Sandeep M Patel; Jun Li; Sahil A Parikh
Journal:  Curr Cardiol Rep       Date:  2015-09       Impact factor: 2.931

9.  Clinical efficacy of percutaneous renal revascularization with stent placement in hypertension among patients with atherosclerotic renovascular diseases.

Authors:  Seyed Mohammad Hassan Adel; Seyed Masood Syeidian; Mohammad Najafi; Mohammad Nourizadeh
Journal:  J Cardiovasc Dis Res       Date:  2011-01

10.  Is race a risk factor for the development of renal artery stenosis?

Authors:  Ayad Jazrawi; Saba Darda; Peter Burke; Marcos Daccarett; Josef Stehlik; Shukri David; Marcel Zughaib
Journal:  Cardiol Res Pract       Date:  2009-11-17       Impact factor: 1.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.